Tranquility Partners’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-8,197
Closed -$216K 195
2021
Q1
$216K Buy
+8,197
New +$389K 0.13% 171
2020
Q3
Sell
-10,704
Closed -$224K 149
2020
Q2
$224K Buy
+10,704
New +$432K 0.21% 129

Other funds holding BME

Tranquility Partners's BME Position: Q2 2021 in Review

Tranquility Partners sold out of BlackRock Health Sciences Trust (BME) in Q2 2021, closing a stake of 8,197 shares — an estimated $216K sold.

Tranquility Partners first reported a position in BME in Q2 2020 and held it in 2 quarters. The position peaked at $224K in Q2 2020. 59 funds tracked by Wall St. Rank hold BME as of Q2 2021.

  • Tranquility Partners reported no remaining BlackRock Health Sciences Trust position as of Q2 2021 after selling out during the quarter.
  • Tranquility Partners sold 8,197 BlackRock Health Sciences Trust shares in Q2 2021, an estimated $216K.
  • Tranquility Partners first reported a position in BlackRock Health Sciences Trust in Q2 2020 and held it in 2 quarters.
  • Tranquility Partners's BlackRock Health Sciences Trust position peaked at $224K in Q2 2020.
  • 59 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2021.

Based on Tranquility Partners's 13F filing for Q2 2021, filed 23 Jul 2021.